CoChat

Innate Immunity Fights Alzheimer's Disease

Open access
Guillot-Sestier, Marie-Victoire, Doty, Kevin R., Town, Terrence · 2015 · Trends in Neurosciences
Cited by 102

The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.

Abstract

Alzheimer’s disease (AD) is the most common age-related dementia. Pathognomonic accumulation of cerebral β-amyloid plaques likely results from imbalanced production and removal of amyloid-β (Aβ) peptides. In AD, innate immune cells lose their ability to restrict cerebral Aβ accumulation. At least in principle, mononuclear phagocytes can be enlisted to clear Aβ/β-amyloid from the brain. While the classical focus has been on dampening neuroinflammation in the context of AD, we hypothesize that rebalancing cerebral innate immunity by inhibiting actions of key anti-inflammatory cytokines returns the brain to a physiological state. Recent experiments demonstrating beneficial effects of blocking anti-inflammatory cytokine signaling in pre-clinical mouse models provide supportive evidence. This concept represents an important step toward innate immune targeted therapy to combat AD.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.tins.2015.08.008

Cites

30 of 30 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 30 references

Cited by

See all 102

Metadata

Authors
Guillot-Sestier, M.-V., Doty, K. R., & Town, T.
Venue
Trends in Neurosciences
Publisher
Elsevier BV
Published
2015-11
Volume
38
Issue
11
Pages
674-681
ISSN
0166-2236 (ISSN-L)
OpenAlex
W2190370706
Cited by
102
References
30
FWCI
1.90
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Innate Immunity Fights Alzheimer's Disease. https://app.cochat.ai/papers/10.1016/j.tins.2015.08.008
The paper
Guillot-Sestier, M.-V., Doty, K. R., & Town, T. (2015). Innate Immunity Fights Alzheimer's Disease. Trends in Neurosciences. https://doi.org/10.1016/j.tins.2015.08.008

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.